Ovarian Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Conditions:   Ovarian High Grade Serous Adenocarcinoma;   Platinum-Resistant Ovarian Carcinoma Interventions:   Drug: Atovaquone;   Procedure: Biopsy;   Procedure: Computed Tomography;   Procedure: Paracentesis Sponsors:   Emory University;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials